PUBLISHER: Inkwood Research | PRODUCT CODE: 1637026
PUBLISHER: Inkwood Research | PRODUCT CODE: 1637026
The Vietnam baby food products market is expected to grow at a CAGR of 1.53% during the forecast period from 2025 to 2032. The market was valued at $1303.60 million in 2024 and is expected to reach a revenue of $1455.99 million by 2032. In terms of volume, the Vietnam baby food products market was valued at 99.45 kilotons in 2024 and is expected to reach 108.34 kilotons by 2032, developing at a CAGR of 1.16% during the forecast period.
The baby food products market in Vietnam is characterized by a mix of international and domestic brands offering a variety of options to consumers. Brands from countries like the United States hold significant consumer trust and preference, with Abbott and Johnson & Johnson being well-recognized names. The retail landscape is dominated by large chains such as Con Cung, Bibo Mart, and Kids Plaza, primarily concentrated in urban centers like Hanoi and Ho Chi Minh City. Con Cung has expanded its reach beyond urban areas, establishing outlets in all provinces across Vietnam, supported by foreign investments. This broader network gives it a considerable advantage in reaching a wider demographic compared to other retail chains, which often focus on metropolitan markets.
The growing role of e-commerce has also influenced the baby food market, with platforms like Shopee, Lazada, and Tiki gaining popularity among consumers. These platforms provide easy access to a range of products for parents nationwide, enabling smaller brands to tap into niche markets that cater to specific needs, such as organic or hypoallergenic baby food options. This shift to digital purchasing reflects changing consumer habits and the demand for convenience.
Nutritional challenges continue to be a significant concern in Vietnam; the Ministry of Health reports that approximately 25% of children under five are stunted due to malnutrition, highlighting a persistent issue with child nutrition. A national nutrition survey conducted in 2023 found that 18% of children below the age of five are classified as stunted, placing Vietnam within the World Health Organization's average range for stunting rates.
At the same time, there have been improvements in child health indicators. The infant mortality rate has decreased from 18 per 1,000 live births in 2010 to 15 per 1,000 live births in 2022. This decline is linked to better access to quality nutrition and healthcare products, reflecting a gradual improvement in the overall health and well-being of children in the country.
E-commerce is increasingly important in improving access to baby food products, with 35% of purchases now being made online, as reported by the Vietnam E-commerce Association. This shift highlights the growing influence of digital platforms in the baby food market, as both established and new brands adjust to the changing preferences of consumers. As a result, the rise of online shopping is reshaping how baby food products are distributed and purchased in Vietnam.
SEGMENTATION ANALYSIS
The report on the Vietnam baby food products market includes segmentation analysis on the basis of category and distribution channel.
Market by Category:
Standard Milk Formula
Follow-on Milk Formula
Growing-Up Milk Formula
Special Baby Milk Formula
Market by Distribution Channel:
Inkwood Research's report on the Vietnam baby food products market provides in-depth insights as well as the market's segmentation analysis. The detailed evaluation of the market includes PESTLE Analysis, Market Maturity Analysis, Market Concentration Analysis, Value Chain Analysis, Key Buying Criteria, and Competitive Landscape.
Major players operating in the Vietnam baby food products market include Abbott Vietnam Co Ltd, Danone Dumex Vietnam Co Ltd, FrieslandCampina Vietnam Co Ltd, Glico Dairy Products Co Ltd, Hipp GmbH & Co Vertrieb KG, Kraft Heinz Co, Mead Johnson Nutrition (Vietnam) Co Ltd, Meiji Holdings Co Ltd, Nestle Vietnam Co Ltd, etc.
Abbott Vietnam Co Ltd, a subsidiary of Abbott Laboratories (Abbott), specializes in the development, production, and distribution of various healthcare products. These include branded generic medicines, diagnostic tools, and nutritional products for both children and adults. The company also provides medical devices for managing conditions such as heart failure, vascular and structural heart issues, electrophysiology, rhythm management, and neuromodulation.
Additionally, Abbott offers minerals, dietary supplements, and nutrition solutions. It operates research and development centers in countries such as the United States, China, India, Colombia, Singapore, Spain, and the United Kingdom, alongside manufacturing facilities in multiple global locations. Its products are marketed across regions including North America, Latin America, Europe, the Middle East, Asia-Pacific, and Africa. The company's headquarters are located in Abbott Park, Illinois, USA.